Home›Stock Screener›Amkay Products›Quarterly Results

Amkay Products Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹3 Cr
QMarch 2025
Quarterly Results

In 2026, Amkay Products (AMKAY) reported revenue ₹18 Cr and net profit ₹1 Cr. For annual financials, live price and key ratios, visit AMKAY stock price BSE.

AMKAY Quarterly Results — Revenue, Profit & EPS Highlights

Amkay Products latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View Amkay Products 52-week for the annual high/low range and current price position.

  • Revenue of ₹40 Cr in March 2025 (+0.0% vs March 2025, +25.0% vs March 2024)
  • Net Profit of ₹3 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
  • EBITDA of ₹5 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 11.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹3.96 in March 2025 (+0.0% vs March 2025)

Amkay Products Quarterly Results — Revenue, EBITDA, Net Profit & EPS

AMKAY quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 18 40 32 28 37 -55.0% -
Net Profit (₹ Cr) 1 3 3 2 2 - -
EBITDA (₹ Cr) 2 5 5 3 3 - -
EPS (₹) 2.10 3.96 4.13 2.43 2.31 - -
Operating Margin (%) 5.0% 11.0% 11.0% 11.0% 7.0% - -

AMKAY Share Price Trend — 1-Year Movement Across Quarterly Results

Amkay Products 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse AMKAY shareholder distribution to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 7.5%
EBITDA Margin 12.5%
Operating Margin 11.0%
ROE (Annual) 12.5%

Balance Sheet Highlights

Total Assets ₹30 Cr
Total Equity ₹24 Cr
Current Assets ₹17 Cr
Current Liabilities ₹1 Cr

Cash Flow Analysis

Operating Cash Flow ₹0 Cr
Investing Cash Flow ₹-6 Cr
Financing Cash Flow ₹8 Cr
Net Cash Flow ₹1 Cr

Revenue Trend (₹ Cr)

March 2023 28
March 2024 32
March 2025 40
2026 18

Net Profit Trend (₹ Cr)

March 2023 2
March 2024 3
March 2025 3
2026 1

Operating Margin Trend (%)

March 2023 11.0%
March 2024 11.0%
March 2025 11.0%
2026 5.0%

AMKAY vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Amkay Products latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹455,633.71 Cr 1861.0 15,018 2,710 -5.6% - 18.0% 164.7
Divis Laboratories
Mar 2026 		₹247,283.98 Cr 9438.5 2,986 751 -5.0% - 25.2% 333.4
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4930.0 4,111 364 +27.7% +42.2% 8.9% 428.3
Zydus Life Science
Mar 2026 		₹116,411.21 Cr 1117.8 7,569 1,341 -4.3% - 17.7% 88.4
Cipla
Mar 2026 		₹110,117.40 Cr 1373.3 6,612 543 -9.3% - 8.2% 199.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores